|
Rodríguez-Arcas MJ, García-Jiménez E, Montesinos-Hernández A, Martínez-Martínez F, Conesa-Zamora P. Pharmacotherapeutic Follow-up and Pharmacogenetics of CYP2C9 and CYP3A4 in Antihypertensive Therapy: A Pilot Study in a Community Pharmacy. Ther Innov Regul Sci. 2013 Jul;47(4):489-494. doi: 10.1177/2168479013492736. PubMed PMID: 30235515.
AÑO: 2013; IF: 0.901
|
30235515
|
Vilchez JR, Torres-Moreno D, Martínez-Senac MM, Trujillo-Santos J, Conesa-Zamora P. Evaluation of the association of NKG2C copy number variations with susceptibility to human papillomavirus-induced cervical lesions. Hum Immunol. 2013 Oct;74(10):1352-6. doi: 10.1016/j.humimm.2013.07.006. PubMed PMID: 23911737.
AÑO: 2013; IF: 2.282
|
|
Conesa-Zamora P, Torres-Moreno D, Isaac MA, Pérez-Guillermo M. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence. Exp Mol Pathol. 2013 Oct;95(2):151-5. doi: 10.1016/j.yexmp.2013.06.011. PubMed PMID: 23827764.
AÑO: 2013; IF: 2.881
|
|
Conesa-Zamora P, García-Solano J, García-García F, Turpin Mdel C, Trujillo-Santos J, Torres-Moreno D, Oviedo-Ramírez I, Carbonell-Muñoz R, Muñoz-Delgado E, Rodriguez-Braun E, Conesa A, Pérez-Guillermo M. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma. Int J Cancer. 2013 Jan 15;132(2):297-307. doi: 10.1002/ijc.27674. PubMed PMID: 22696308.
AÑO: 2013; IF: 5.007
|
|
Ruiz-Cosano J, Torres-Moreno D, Conesa-Zamora P. Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population. J BUON. 2013 Apr-Jun;18(2):486-90. PubMed PMID: 23818366.
AÑO: 2013; IF: 0.706
|